Barclays Cuts Molina Healthcare (NYSE:MOH) Price Target to $185.00

Key Points

• Barclays has reduced its price target for Molina Healthcare's stock from $186.00 to $185.00, maintaining an "equal weight" rating, indicating modest expectations for the stock's performance.
• Molina Healthcare recently reported a 4.4% decline in its stock price, reaching $169.17, amidst a variety of analyst downgrades affecting the stock's outlook.
• The company's latest earnings report showed a slight miss in earnings per share compared to estimates, but a significant increase in quarterly revenue, rising 15.7% over last year.

Molina Healthcare (NYSE:MOH - Free Report) had its price objective cut by Barclays from $186.00 to $185.00 in a research note issued to investors on Thursday,Benzinga reports. They currently have an equal weight rating on the stock.

MOH has been the subject of a number of other research reports. Truist Financial reaffirmed a "hold" rating and set a $180.00 target price (down previously from $335.00) on shares of Molina Healthcare in a report on Friday, July 25th. Robert W. Baird lowered their target price on shares of Molina Healthcare from $373.00 to $179.00 and set a "neutral" rating for the company in a report on Friday, July 25th. UBS Group lowered their target price on shares of Molina Healthcare from $260.00 to $180.00 and set a "neutral" rating for the company in a report on Friday, July 25th. Morgan Stanley lowered shares of Molina Healthcare from an "overweight" rating to an "equal weight" rating and lowered their target price for the stock from $364.00 to $266.00 in a report on Thursday, July 10th. Finally, JPMorgan Chase & Co. decreased their price target on shares of Molina Healthcare from $272.00 to $184.00 and set a "neutral" rating for the company in a report on Tuesday, July 29th. Three research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. According to MarketBeat, the company presently has an average rating of "Hold" and an average target price of $225.18.

Molina Healthcare Price Performance

MOH traded up $3.68 during trading on Thursday, hitting $174.51. The company's stock had a trading volume of 1,294,913 shares, compared to its average volume of 1,435,618. The stock has a market capitalization of $9.46 billion, a price-to-earnings ratio of 8.60 and a beta of 0.54. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.77. The firm's 50 day moving average price is $187.75 and its two-hundred day moving average price is $269.88. Molina Healthcare has a 12 month low of $151.95 and a 12 month high of $365.23.

Molina Healthcare (NYSE:MOH - Get Free Report) last released its earnings results on Wednesday, July 23rd. The company reported $5.48 earnings per share for the quarter, missing analysts' consensus estimates of $5.50 by ($0.02). The firm had revenue of $11.43 billion for the quarter, compared to the consensus estimate of $10.94 billion. Molina Healthcare had a return on equity of 27.72% and a net margin of 2.60%.The company's revenue was up 15.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $5.86 EPS. Sell-side analysts forecast that Molina Healthcare will post 24.4 earnings per share for the current fiscal year.

Insider Buying and Selling at Molina Healthcare

In other Molina Healthcare news, COO James Woys purchased 10,000 shares of the business's stock in a transaction on Monday, August 4th. The shares were purchased at an average cost of $155.94 per share, with a total value of $1,559,400.00. Following the transaction, the chief operating officer directly owned 74,331 shares of the company's stock, valued at $11,591,176.14. This represents a 15.54% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Ronna Romney sold 700 shares of the business's stock in a transaction dated Wednesday, August 6th. The stock was sold at an average price of $153.74, for a total transaction of $107,618.00. Following the sale, the director directly owned 17,131 shares in the company, valued at $2,633,719.94. This trade represents a 3.93% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.10% of the company's stock.

Institutional Investors Weigh In On Molina Healthcare

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Teacher Retirement System of Texas bought a new stake in Molina Healthcare during the 1st quarter worth about $2,759,000. Farther Finance Advisors LLC increased its stake in shares of Molina Healthcare by 100.3% during the 1st quarter. Farther Finance Advisors LLC now owns 659 shares of the company's stock worth $216,000 after purchasing an additional 330 shares during the last quarter. Robeco Institutional Asset Management B.V. acquired a new position in shares of Molina Healthcare during the 1st quarter worth about $1,070,000. Wealth Enhancement Advisory Services LLC increased its stake in shares of Molina Healthcare by 82.1% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 15,635 shares of the company's stock worth $5,150,000 after purchasing an additional 7,051 shares during the last quarter. Finally, Wealthcare Advisory Partners LLC acquired a new position in shares of Molina Healthcare during the 1st quarter worth about $255,000. 98.50% of the stock is owned by institutional investors.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.